Methylene blue inhibits the function of α7-nicotinic acetylcholine receptors

CNS and Neurological Disorders - Drug Targets

Volumn 11, Issue 6, 2012, Pages 791-800

  Al Mansouri, Abdulla S ^a   Lorke, Dietrich E ^b   Nurulain, Syed M ^a   Ashoor, Abrar ^a   Keun Hang, Susan Yang ^c   Petroianu, Georg ^b   Isaev, Dmytro ^a   Oz, Murat ^a,b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^c CHAPMAN UNIVERSITY   (United States)

Author keywords

Electrophysiology; Hippocampal slices; Methylene blue; Nicotinic receptors; Xenopus oocyte

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINE; ALPHA BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; CHLORPROMAZINE; COMPLEMENTARY DNA; METHYLENE BLUE; RADIOLIGAND;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EXTRACELLULAR CALCIUM; GABAERGIC SYSTEM; HIPPOCAMPAL CA1 REGION; IC 50; MALE; MEMBRANE RESISTANCE; MEMBRANE STEADY POTENTIAL; NONHUMAN; OOCYTE; RADIOASSAY; RAT; VOLTAGE CLAMP; XENOPUS LAEVIS;

ALZHEIMER DISEASE; ANIMALS; BUNGAROTOXINS; CA1 REGION, HIPPOCAMPAL; ENZYME INHIBITORS; GABA AGENTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MEMBRANE POTENTIALS; METHYLENE BLUE; NICOTINIC ANTAGONISTS; OOCYTES; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; XENOPUS LAEVIS;

EID: 84868087867     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152712803581010     Document Type: Article

References (66)

1. Wainwright, M.; Crossley, K.B. Methylene Blue--a therapeutic dye for all seasons? J. Chemother., 2002, 14(5), 431-443.
2. Oz, M.; Lorke, D.E.; Hasan, M.; Petroianu, G.A. Cellular and molecular actions of methylene blue in the nervous system. Med. Res. Rev., 2011, 31, 93-117.
3. Oz, M.; Lorke, D.E.; Petroianu, G.A. Methylene blue and Alzheimer's disease. Biochem. Pharmacol., 2009, 78(8), 927-932.
4. Atamna, H.; Nguyen, A.; Schultz, C.; Boyle, K.; Newberry, J.; Kato, H.; Ames, B.N. Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. FASEB J., 2008, 22(3), 703-712.
5. Hattori, M.; Sugino, E.; Minoura, K.; In, Y.; Sumida, M.; Taniguchi, T.; Tomoo, K.; Ishida, T. Different inhibitory response of cyanidin and methylene blue for filament formation of tau microtubule-binding domain. Biochem. Biophys. Res. Commun., 2008, 374(1), 158-163.
6. Necula, M.; Breydo, L.; Milton, S.; Kayed, R.; van der Veer, W.E.; Tone, P.; Glabe, C.G. Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry, 2007, 46(30), 8850-8860.
7. Riedel, W.; Lang, U.; Oetjen, U.; Schlapp, U.; Shibata, M. Inhibition of oxygen radical formation by methylene blue, aspirin, or alpha-lipoic acid, prevents bacterial-lipopolysaccharide-induced fever. Mol. Cell Biochem., 2003, 247(1-2), 83-94.
8. Taniguchi, S.; Suzuki, N.; Masuda, M.; Hisanaga, S.; Iwatsubo, T.; Goedert, M.; Hasegawa, M. Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J. Biol. Chem., 2005, 280(9), 7614-7623.
9. Wischik, C.M.; Edwards, P.C.; Lai, R.Y.; Roth, M.; Harrington, C.R. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc. Natl. Acad. Sci. USA, 1996, 93(20), 11213-11218.
10. Callaway, N.L.; Riha, P.D.; Bruchey, A.K.; Munshi, Z.; Gonzalez-Lima, F. Methylene blue improves brain oxidative metabolism and memory retention in rats. Pharmacol. Biochem. Behav., 2004, 77(1), 175-181.
11. Deiana, S.; Harrington, C.R.; Wischik, C.M.; Riedel, G. Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. Psychopharmacology(Berl.), 2009, 202(1-3), 53-65.
12. Gonzalez-Lima, F.; Bruchey, A.K. Extinction memory improvement by the metabolic enhancer methylene blue. Learn. Mem., 2004, 11(5), 633-640.
13. Riha, P.D.; Bruchey, A.K.; Echevarria, D.J.; Gonzalez-Lima, F. Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. Eur. J. Pharmacol., 2005, 511(2-3), 151-158.
14. Wrubel, K.M.; Riha, P.D.; Maldonado, M.A.; McCollum, D.; Gonzalez-Lima, F. The brain metabolic enhancer methylene blue improves discrimination learning in rats. Pharmacol. Biochem. Behav., 2007, 86(4), 712-717.
15. Gura, T. Hope in Alzheimer's fight emerges from unexpected places. Nat. Med., 2008, 14(9), 894.
16. Wischik, C.M.; Bentham, P.; Wischik, D.J.; Seng, K.M. Tau aggregation inhibitor(TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks. Alzheimers & Dement., 2008, 4(4), T167.
17. Grinevich, V.P.; Papke, R.L.; Lippiello, P.M.; Bencherif, M. Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors. Neuropharmacology, 2009, 57(2), 183-191.
18. Nagele, R.G.; D'Andrea, M.R.; Anderson, W.J.; Wang, H.Y. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience, 2002, 110(2), 199-211.
19. Ripoll, N.; Bronnec, M.; Bourin, M. Nicotinic receptors and schizophrenia. Curr. Med. Res. Opin., 2004, 20(7), 1057-1074.
20. Thomsen, M.S.; Hansen, H.H.; Timmerman, D.B.; Mikkelsen, J.D. Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr. Pharm. Des., 2010, 16(3), 323-343.
21. Dziewczapolski, G.; Glogowski, C.M.; Masliah, E.; Heinemann, S.F. Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease. J. Neurosci., 2009, 29(27), 8805-8815.
22. Oz, M.; Spivak, C.E.; Lupica, C.R. The solubilizing detergents, Tween 80 and Triton X-100 non-competitively inhibit alpha 7-nicotinic acetylcholine receptor function in Xenopus oocytes. J. Neurosci. Methods, 2004, 137(2), 167-173.
23. Oz, M.; Melia, M.T.; Soldatov, N.M.; Abernethy, D.R.; Morad, M. Functional coupling of human L-type Ca2+ channels and angiotensin AT1A receptors coexpressed in xenopus laevis oocytes: involvement of the carboxyl-terminal Ca2+ sensors. Mol. Pharmacol., 1998, 54(6), 1106-1112.
24. Oz, M.; Zakharova, I.; Dinc, M.; Shippenberg, T. Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes. Naunyn Schmiedebergs Arch. Pharmacol., 2004, 369(2), 252-259.
25. Hoffman, A.F.; Oz, M.; Yang, R.; Lichtman, A.H.; Lupica, C.R. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn. Mem., 2007, 14(1-2), 63-74.
26. Sands, S.B.; Costa, A.C.; Patrick, J.W. Barium permeability of neuronal nicotinic receptor alpha 7 expressed in Xenopus oocytes. Biophys. J., 1993, 65(6), 2614-2621.
27. Seguela, P.; Wadiche, J.; Dineley-Miller, K.; Dani, J.A.; Patrick, J.W. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci., 1993, 13(2), 596-604.
28. Kim, E.; Tam, M.; Siems, W.F.; Kang, C. Effects of drugs with muscle-related side effects and affinity for calsequestrin on the calcium regulatory function of sarcoplasmic reticulum microsomes. Mol. Pharmacol., 2005, 68(6), 1708-1715.
29. Lee, Y.S.; Wurster, R.D. Methylene blue induces cytotoxicity in human brain tumor cells. Cancer Lett., 1995, 88(2), 141-145.
30. Palacios, J.; Sepulveda, M.R.; Lee, A.G.; Mata, A.M. Ca2+ transport by the synaptosomal plasma membrane Ca2+-ATPase and the effect of thioridazine. Biochemistry 2004, 43(8), 2353-2358.
31. Quamme, G.A. Chlorpromazine activates chloride currents in Xenopus oocytes. Biochim. Biophys. Acta, 1997, 1324(1), 18-26.
32. DiSanto, A.R.; Wagner, J.G. Pharmacokinetics of highly ionized drugs. II. Methylene blue--absorption, metabolism, and excretion in man and dog after oral administration. J. Pharm. Sci., 1972, 61(7), 1086-1090.
33. Albuquerque, E.X.; Pereira, E.F.; Alkondon, M.; Rogers, S.W. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev., 2009, 89(1), 73-120.
34. Fraser, S.P.; Djamgoz, M.B. A. Xenopus oocytes: Endogenous electrophysiological characteristics. In: Current Aspects of the Neurosciences; Osborne, N.N., Ed.; The Macmillan Press, 1992, Vol. 4, pp. 267-315.
35. Hille, B. Ion Channels of Excitable Membranes. 3rd ed.; Sinauer Associates: Sunderland, MA, 2001.
36. Onaran, H.O.; Costa, T. Allosteric coupling and conformational fluctuations in proteins. Curr. Protein Pept. Sci., 2009, 10(2), 110-115.
37. Aeschlimann, C.; Cerny, T.; Kupfer, A. Inhibition of(mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue. Drug Metab. Dispos., 1996, 24(12), 1336-1339.
38. O'Leary, J.L.; Petty, J.; Harris, A.B.; Inukai, J. Supravital staining of mammalian brain with intra-arterial methylene blue followed by pressurized oxygen. Stain Technol., 1968, 43(4), 197-201.
39. Peter, C.; Hongwan, D.; Kupfer, A.; Lauterburg, B.H. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur. J. Clin. Pharmacol., 2000, 56(3), 247-250.
40. Muller, T. Methylene blue supravital staining: an evaluation of its applicability to the mammalian brain and pineal gland. Histol. Histopathol., 1998, 13(4), 1019-1026.
41. O'Leary, J.C., 3rd; Li, Q.; Marinec, P.; Blair, L.J.; Congdon, E.E.; Johnson, A.G.; Jinwal, U.K.; Koren, J., 3rd; Jones, J.R.; Kraft, C.; Peters, M.; Abisambra, J.F.; Duff, K.E.; Weeber, E.J.; Gestwicki, J.E.; Dickey, C.A. Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Mol. Neurodegener., 2010, 5, 45.
42. Nemeth, P.R.; Daly, K.; Erde, S.; Wood, J.D. Effects of methylene blue on electrical behavior of myenteric neurons. Experientia, 1985, 41(2), 259-261.
43. Stockand, J.D.; Sansom, S.C. Activation by methylene blue of large Ca(2+)-activated K+ channels. Biochim. Biophys. Acta, 1996, 1285(2), 123-126.
44. Armstrong, C.M.; Croop, R.S. Simulation of Na channel inactivation by thiazine dyes. J. Gen. Physiol., 1982, 80(5), 641-662.
45. Starkus, J.G.; Heggeness, S.T.; Rayner, M.D. Kinetic analysis of sodium channel block by internal methylene blue in pronased crayfish giant axons. Biophys. J., 1984, 46(2), 205-218.
46. Fujii, S.; Ji, Z.; Sumikawa, K. Inactivation of alpha7 ACh receptors and activation of non-alpha7 ACh receptors both contribute to long term potentiation induction in the hippocampal CA1 region. Neurosci. Lett., 2000, 286(2), 134-138.
47. Guan, X.; Nakauchi, S.; Sumikawa, K. Nicotine reverses consolidated long-term potentiation in the hippocampal CA1 region. Brain Res. 2006, 1078(1), 80-91.
48. Buckingham, S.D.; Jones, A.K.; Brown, L.A.; Sattelle, D.B. Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection. Pharmacol. Rev., 2009, 61(1), 39-61.
49. Dineley, K.T. Beta-amyloid peptide--nicotinic acetylcholine receptor interaction: the two faces of health and disease. Front. Biosci., 2007, 12, 5030-5038.
50. Mozayan, M.; Chen, M.F.; Si, M.; Chen, P.Y.; Premkumar, L.S.; Lee, T.J. Cholinesterase inhibitor blockade and its prevention by statins of sympathetic alpha7-nAChR-mediated cerebral nitrergic neurogenic vasodilation. J. Cereb. Blood Flow Metab., 2006, 26(12), 1562-1576.
51. Mozayan, M.; Lee, T.J. Statins prevent cholinesterase inhibitor blockade of sympathetic alpha7-nAChR-mediated currents in rat superior cervical ganglion neurons. Am. J. Physiol. Heart Circ. Physiol., 2007, 293(3), H1737-H1744.
52. Pereira, E.F.; Alkondon, M.; Tano, T.; Castro, N.G.; Froes-Ferrao, M.M.; Rozental, R.; Aronstam, R.S.; Schrattenholz, A.; Maelicke, A.; Albuquerque, E.X. A novel agonist binding site on nicotinic acetylcholine receptors. J. Recept. Res., 1993, 13(1-4), 413-436.
53. Samochocki, M.; Hoffle, A.; Fehrenbacher, A.; Jostock, R.; Ludwig, J.; Christner, C.; Radina, M.; Zerlin, M.; Ullmer, C.; Pereira, E.F.; Lubbert, H.; Albuquerque, E.X.; Maelicke, A. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther., 2003, 305(3), 1024-1036.
54. Aracava, Y.; Pereira, E.F.; Maelicke, A.; Albuquerque, E.X. Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than n-methyl-D-aspartate receptors in rat hippocampal neurons. J. Pharmacol. Exp. Ther., 2005, 312(3), 1195-1205.
55. Maskell, P.D.; Speder, P.; Newberry, N.R.; Bermudez, I. Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors. Br. J. Pharmacol., 2003, 140(7), 1313-1319.
56. Banerjee, P.; Samoriski, G.; Gupta, S. Comments on Memantine blocks alpha7* nicotinic acetylcholine receptors more potently than N-methyl-D-aspartate receptors in rat hippocampal neurons. J. Pharmacol. Exp. Ther., 2005, 313(2), 928-929; author reply 930-933.
57. Quick, M.W.; Lester, R.A. Desensitization of neuronal nicotinic receptors. J. Neurobiol., 2002, 53(4), 457-478.
58. Hernandez, C.M.; Kayed, R.; Zheng, H.; Sweatt, J.D.; Dineley, K.T. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease. J. Neurosci., 2010, 30(7), 2442-2453.
59. Parri, H.R.; Hernandez, C.M.; Dineley, K.T. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. Biochem. Pharmacol., 2011, 82(8), 931-942.
60. Congdon, E.E.; Wu, J.W.; Myeku, N.; Figueroa, Y.H.; Herman, M.; Marinec, P.S.; Gestwicki, J.E.; Dickey, C.A.; Yu, W.H.; Duff, K. Methylthioninium chloride(methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy, 2012, 8(4) (Epub ahead of print).
61. Medina, D.X.; Caccamo, A.; Oddo, S. Methylene blue reduces a levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol., 2011, 21(2), 140-149.
62. Atamna, H.; Kumar, R. Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase. J. Alzheimers Dis., 2010, 20(Suppl 2), S439-S452.
63. Kelner, M.J.; Bagnell, R.; Hale, B.; Alexander, N.M. Potential of methylene blue to block oxygen radical generation in reperfusion injury. Basic Life Sci., 1988, 49, 895-898.
64. Pfaffendorf, M.; Bruning, T.A.; Batnik, H.D.; van Zwieten, P.A. The interaction between methylene blue and the cholinergic system. Br. J. Pharmacol., 1997, 122, 95-98.
65. Lorke, D.E.; Hasan, M.Y.; Nurulain, S.M.; Shafiullah, M.; Kua, K.; Petroianu, G.A. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors. J. Appl. Toxicol., 2011, 31, 515-523.
66. Sullivan, M. Phase II findings in a drug trial 'not all bad'. Clin. Psychiatry News, 2008, 36(11), 34-35.